Sarepta Therapeutics (SRPT) Tax Rate (2017 - 2026)
Sarepta Therapeutics (SRPT) posted quarterly Tax Rate of 3.56% for Q1 2026, up 2024.0% year-over-year from 0.17% in Q1 2025, and up 315.78% quarter-over-quarter from 1.65% in Q4 2025.
Powered by 
Analysis
Sarepta Therapeutics (SRPT) Tax Rate (2017 - 2026) Analysis & Trends
Sarepta Therapeutics' Tax Rate history runs 10 years deep, the most recent figure standing at 3.56% for Q1 2026.
- In Q1 2026, Tax Rate rose 2024.0% year-over-year to 3.56%; the TTM figure through Mar 2026 stood at 166.01% (down 11457.0% YoY), while the FY2025 annual figure was 1.59%, down 1148.0% from the prior year.
- Tax Rate for Q1 2026 stood at 3.56%, up from 1.65% in the prior quarter.
- The five-year high for Tax Rate was 52.42% in Q2 2024, with the low at 64.14% in Q2 2023.
- The 5-year median for Tax Rate is 0.78% (2023), against an average of 3.72%.
- The sharpest annual moves came in 2024 and 2025: Tax Rate jumped 11656 bps in 2024, then slumped 8060 bps in 2025.
- Sarepta Therapeutics' Tax Rate stood at 2.35% in 2022, then slumped by 639 bps to 12.68% in 2023, then soared by 159 bps to 7.54% in 2024, then tumbled by 122 bps to 1.65% in 2025, then jumped by 316 bps to 3.56% in 2026.
- Business Quant data shows SRPT's Tax Rate at 3.56% in Q1 2026, 1.65% in Q4 2025, and 7.27% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -16.71% |
| 10 | Sarepta Therapeutics | 2.36 Bn | 1.57 Bn | 251.87 Mn | -179.59% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -179.59% |
| Mar 31, 2026 | 3.56% |
| Dec 31, 2025 | -1.77% |
| Sep 30, 2025 | 7.27% |
| Jun 30, 2025 | -28.18% |
| Mar 31, 2025 | -16.69% |
| Dec 31, 2024 | 7.54% |
| Sep 30, 2024 | 1.18% |
| Jun 30, 2024 | 52.42% |
| Mar 31, 2024 | 12.86% |
| Dec 31, 2023 | -12.77% |
| Sep 30, 2023 | -23.51% |
| Jun 30, 2023 | -64.45% |
| Mar 31, 2023 | -0.79% |
| Dec 31, 2022 | -8.44% |
| Sep 30, 2022 | -0.51% |
| Jun 30, 2022 | -1.49% |
| Mar 31, 2022 | -0.84% |
| Dec 31, 2021 | -0.08% |
| Sep 30, 2021 | -0.49% |